Quarterly report pursuant to Section 13 or 15(d)

CONDENSED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

v3.21.2
CONDENSED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Revenues:        
Total revenues $ 264 $ 1,018 $ 1,391 $ 3,393
Operating expenses:        
Cost of goods sold 0 0 199 0
Research and development 1,193 887 4,716 4,343
Selling, general and administrative 979 1,327 3,341 4,052
Total operating expenses 2,172 2,214 8,256 8,395
Loss from operations (1,908) (1,196) (6,865) (5,002)
Other income (expense):        
Interest expense, net 0 (246) (2) (718)
Non-cash loss on changes in the fair value of warrants 0 0 0 (923)
Gain on debt extinguishment 0 0 661 0
Other expense, net (7) (13) (30) (233)
Other income (expense), net (7) (259) 629 (1,874)
Loss from continuing operations (1,915) (1,455) (6,236) (6,876)
Loss from discontinued operations 0 (3,477) 0 (8,281)
Net loss and comprehensive loss $ (1,915) $ (4,932) $ (6,236) $ (15,157)
Basic and diluted net loss per common share from continuing operations $ (0.19) $ (0.45) $ (0.64) $ (2.25)
Basic and diluted net loss per common share from discontinued operations $ 0 $ (1.07) $ 0 $ (2.70)
Weighted average shares used in computing basic net loss per common share 9,864 3,264 9,675 3,062
Weighted average shares used in computing diluted net loss per common share 9,864 3,264 9,675 3,062
License revenue        
Revenues:        
Total revenues $ 4 $ 0 $ 9 $ 6
Product revenue        
Revenues:        
Total revenues 36 0 236 39
Grant revenue        
Revenues:        
Total revenues $ 224 $ 1,018 $ 1,146 $ 3,348